Topic: Primary Care Research Network for England
Conditions
Interventions
10 GP practices will be randomised to either the intervention or control arm. Both groups will undertake two audits of liver care, one before the intervention and one after.
Control:
Intervention, The intervention practices will receive the services of a liver health nurse, who will facilitate three intervention modules:
Intervention Module 1
Impro
Details: Identified in an initial audit of liver care and contacted with a letter and information leaflet.
Sponsors
University of Southampton (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Pre-Intervention Audit and Post-Intervention Audit 1. Elevated ALT (above ULN), other abnormal liver function test (Alk Phos or bilirubin above ULN, or Albumin 40 and no type 2 diabetes 4. patients with clinical record suggestive of hazardous alcohol use will be enrolled in Module 3 where appropriate Intervention Module 3: 1. A sample (1000) of patients aged 30 to 65 together with any patients with suspected alcohol misuse from clinical records will be sent a postal invitation as part of the practice liver health programme. The invitation will include an AUDIT questionnaire 2. WHO AUDIT score either > 15 or >7 with alcohol intake on 4 days or more (AUDIT Q1), and alcohol intake of 7 units or more on a drinking occasion (AUDIT Q2) or estimated weekly alcohol intake > 28 units. Target Gender: Male & Female; Upper Age Limit 65 years ; Lower Age Limit 30 years
Exclusion criteria
Exclusion criteria: Pre-Intervention Audit and Post-Intervention Audit: 1. Patients with known terminal illness. Intervention Module 1: 1. Patients with known terminal illness. Intervention Module 2: 1. Patients with known terminal illness. 2. Patients with alcohol misuse will be enrolled via Module 3 where appropriate Intervention Module 3: 1. Patients with known terminal illness 2. Patients identified on GP system as having pre-existing liver disease. 3. Those invited for a check in module 2
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effectiveness and cost effectiveness of the detection and management of liver disease; Timepoint(s): 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Impact of risk stratification on behaviours in patients consuming harmful/hazardous alcohol levels; Timepoint(s): 12 months 2. Increased detection rate of serious liver disease; Timepoint(s): 12 months | — |
Countries
United Kingdom
Outcome results
None listed